Apollon Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
4,628
+98
+2% +$22.8K 0.14% 126
2026
Q1
$1.11M Buy
4,530
+361
+9% +$84.1K 0.15% 118
2025
Q4
$863K Buy
4,169
+1,229
+42% +$243K 0.13% 127
2025
Q3
$545K Buy
2,940
+536
+22% +$91.8K 0.09% 145
2025
Q2
$367K Sell
2,404
-48
-2% -$7.38K 0.08% 171
2025
Q1
$407K Buy
2,452
+371
+18% +$58K 0.1% 150
2024
Q4
$301K Sell
2,081
-133
-6% -$20.6K 0.07% 158
2024
Q3
$359K Buy
2,214
+124
+6% +$19.8K 0.11% 123
2024
Q2
$306K Sell
2,090
-33
-2% -$4.91K 0.1% 115
2024
Q1
$336K Buy
2,123
+44
+2% +$7K 0.12% 112
2023
Q4
$326K Buy
+2,079
New +$319K 0.13% 107

Other funds holding JNJ

Apollon Financial's JNJ Position: Q2 2026 in Review

Apollon Financial increased its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, buying an estimated $22.8K and bringing the position to 4,628 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #126.

Apollon Financial first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Apollon Financial held 4,628 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
  • Apollon Financial bought 98 Johnson & Johnson shares in Q2 2026, an estimated $22.8K.
  • Johnson & Johnson made up 0.14% of Apollon Financial's portfolio in Q2 2026, its #126 holding.
  • Apollon Financial first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.